Follow-up of neuroblastoina stage IV by 123I-mIBG-scintigraphy, bone scintigraphy and catecholamine metabolites;Verlaufskontrolle des neuroblastoms stadium IV: 123I-mIBG-szintigraphie, knochenszintigraphie und katecholaminmetabolite

NuklearMedizin

Volumn 35, Issue 6, 1996, Pages 220-224

  Kohnert, K ^a   Lerch, H ^a   Thelen, M ^a   Schober, O ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Bone scintigraphy; Catecholamine metabolites; mIBG scintigraphy; Neuroblastoma

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; ENOLASE; FERRITIN; HOMOVANILLIC ACID; LACTATE DEHYDROGENASE; MEDRONATE TECHNETIUM TC 99M; POTASSIUM PERCHLORATE; VANILLIC ACID;

ARTICLE; BONE SCINTISCANNING; CANCER SCINTISCANNING; CATECHOLAMINE METABOLISM; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; METASTASIS; NEUROBLASTOMA;

3-IODOBENZYLGUANIDINE; BONE AND BONES; BONE NEOPLASMS; BRAIN NEOPLASMS; CATECHOLAMINES; CHILD; CHILD, PRESCHOOL; FERRITINS; FOLLOW-UP STUDIES; HOMOVANILLIC ACID; HUMANS; INFANT; IODINE RADIOISOTOPES; IODOBENZENES; L-LACTATE DEHYDROGENASE; NEOPLASM METASTASIS; NEOPLASM STAGING; NEUROBLASTOMA; PHOSPHOPYRUVATE HYDRATASE; RECURRENCE; RETROSPECTIVE STUDIES; TIME FACTORS; VANILLIC ACID;

EID: 0030474485     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1629779     Document Type: Article

References (21)

1. Berthold F, Burdoch S, Kremenes B, Lampert F, Niethammer D, Riehm A, Ritter J, Treuner J, Utsch S, Zieschang J. The role of chemotherapy in the treatment of children with neuroblastoma stage IV: the GPO (German Pediatric Oncology Society) experience. Klin Pediatr 1990; 202: 262-9.
2. Daubenton J, Fisher R, Karabus C et al. The relationship between prognosis and scintigraphic evidence of bone metastases in neuroblastoma. Cancer 1987; 59: 1586-9.
3. Evans A, D'Angio G, Koop G. Diagnosis and treatment of Neuroblastoma. Pediatr Clin North Am 1976; 23: 161-70.
4. 123I-mIBG-Szintigraphie in der Diagnostik des Neuroblastoms. Nuklearmedizin 1994; 33: V88.
5. Feine U, Müller-Schaufenburg W, Treuner J et al. Radiojod-markiertes mIBG in der Diagnostik und Therapie von Neuroblastomen. Der Nuklearmediziner 1987; 10: 293-306.
6. Gahr M, Hunnemann D. The value of determination of homovanillic and vanillymandelic acids in plasma for the diagnosis and follow-up of neuroblastoma in children. Eur J Pediatr 1987; 146: 489-93.
7. Giammarile F, Lumbroso J, Ricard M et al. Radioiodinated metaiodobenzylguanidine in neuroblastoma: influence of high dose on tumour site detection. Eur J Nucl Med 1995; 22: 1180-3.
8. Gilday D, Greenberg M. Editorial: The controversy about the nuclear medicine investigation of neuroblastoma. J Nucl Med 1989; 31: 135.
9. 123I-mIBG scans. J Nucl Med 1990; 31: 129-34.
10. 131I-mIBG: Diagnostic use in neuroblastoma patients in relapse. Med Pediatr Oncol 1988; 16: 337-40.
11. Kimmig B, Brandeis W, Eisenhut M et al. Szintigraphische Diagnostik des Neuroblastoms mit mIBG. Klin Pädiat 1986; 198: 224-9.
12. Labreveux de Cervens C, Hartmann O, Bonnin F et al. What is the prognostic value of osteomedullary uptake on mIBG scan in neuroblastoma patients under one year of age? Med Pediatr Oncol 1994; 22: 107-14.
13. 131I-mIBG imaging to monitor chemotherapy response in advanced neuroblastoma: comparison with laboratory analysis. J Nucl Med 1994; 35: 1429-35.
14. Moyes J, McCready V, Fullbrook A. Neuroblastoma: mIBG in diagnosis and management. Berlin, Heidelberg, New York: Springer Verlag 1989; 5-20.
15. 123I-mIBG scintigraphy and single bone marrow aspiration biopsy in the diagnosis and follow-up of 26 children with neuroblastoma. Eur J Nucl Med 1993; 20: 1154-60.
16. 99mTc-MDP-Skelettszintigraphie beim Neuroblastom. Nuklearmedizin 1991; 30: 7-11.
17. 131I-mIBG and bone scintigraphy for the detection of neuroblastoma. J Nucl Med 1992; 33: 1735-40.
18. 131I-mIBG scanning for the detection of skeletal and extraskeletal neuroblastoma. Eur J Nucl Med 1991; 18: 553.
19. West GJ, Uki J, Herschmann HR et al. Adrenergic, cholinergic and inactive human neuroblastoma cell lines with action potential Na-ionophore. Cancer Res 1977; 37: 1372-6.
20. 131I-mIBG: concise communication. J Nucl Med 1981; 22: 358-64.
21. 131I-Iodobenzyl-guanidine. J Nucl Med 1980; 21: 349-53.